SAFETY AND REGULATORY CENTER

Clear boundaries for high-risk peptide content.

The atlas separates clinical evidence, product status, safety warnings, and marketing claims so readers do not confuse availability with approval or proof.

Approval is product-specific

FDA approval is tied to a product, label, sponsor, route, indication, and manufacturing context.

Compounded is not FDA-approved

Compounded products can have legitimate clinical roles, but they are generally not FDA-approved products.

RUO is not a human-use pathway

Research-use-only labeling is not a consumer safety claim and not a dosing pathway.

Cosmetic listing is not clinical proof

Cosmetic products and ingredients are regulated differently from drugs and cannot claim to treat disease.

Supplement status is not drug approval

Dietary supplements cannot rely on FDA drug approval language for treatment claims.

Athlete caution

Sport status can change and may differ by federation; athletes should verify current WADA and sport rules.